Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-11-08Clinical Trial Update: A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Pfizer completed a Phase 2 randomized, open-label study of CI-1033 as a single agent in patients with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2006-11-08Clinical Trial Update: PH 1 Evaluation Of Oral CI-1033 In Combination With Paclitaxel/ Carboplatin As 1st Line Chemotherapy In NSCLC Patients [Phase 1]
A Pfizer-sponsored Phase 1 trial evaluated oral CI-1033 in combination with paclitaxel and carboplatin as first-line therapy for non-small c…
-
CLINICAL_TRIALS trial_result · 2006-07-24Clinical Trial Update: Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy [Phase 2]
A Phase 2 trial evaluating gemcitabine in combination with cisplatin as neoadjuvant chemotherapy for non-small cell lung cancer has been com…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. [Phase 2]
This document reports the completion of a Phase 2 trial evaluating pemetrexed (ALIMTA) in combination with carboplatin as first-line chemoth…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: Comparing 3 Schedules of Alimta Plus Gemzar [Phase 2]
This Phase 2 trial compared three schedules of Alimta (pemetrexed) plus Gemzar (gemcitabine) in Non-Small Cell Lung Cancer and has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: A Phase 2 Trial of Antisense Nucleotide to PKC-Alpha (LY900003, ISIS 3521) Plus Gemcitabine and Carboplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer. [Phase 2]
Phase 2 trial evaluating antisense PKC-α inhibitor LY900003 (ISIS 3521) with gemcitabine and carboplatin in previously untreated advanced no…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing LY900003 plus gemcitabine and cisplatin to gemcitabine and cisplatin in patients with advanced, untreated non-small …